These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 33963001

  • 21. Pathological confirmation of para-aortic lymph node status as a potential criterion for the selection of intrahepatic cholangiocarcinoma patients for radical resection with regional lymph node dissection.
    Nakayama T, Tsuchikawa T, Shichinohe T, Nakamura T, Ebihara Y, Hirano S.
    World J Surg; 2014 Jul; 38(7):1763-8. PubMed ID: 24378552
    [Abstract] [Full Text] [Related]

  • 22. Has Management of Intrahepatic Cholangiocarcinoma Evolved with the Evidence? Trends and Practice Patterns from the National Cancer Database.
    Schleimer LE, Kalvin HL, Ellis RJ, Kingham TP, Soares KC, D'Angelica MI, Balachandran VP, Drebin J, Cercek A, Abou-Alfa GK, O'Reilly EM, Harding JJ, Gönen M, Wei AC, Jarnagin WR.
    Ann Surg Oncol; 2024 Oct; 31(10):6551-6563. PubMed ID: 39042229
    [Abstract] [Full Text] [Related]

  • 23. Prognostic factors of intrahepatic cholangiocarcinoma after hepatic resection: univariate and multivariate analysis.
    Hanazaki K, Kajikawa S, Shimozawa N, Shimada K, Hiraguri M, Koide N, Adachi W, Amano J.
    Hepatogastroenterology; 2002 Oct; 49(44):311-6. PubMed ID: 11995440
    [Abstract] [Full Text] [Related]

  • 24. Genomic profiling of intrahepatic cholangiocarcinoma: refining prognosis and identifying therapeutic targets.
    Zhu AX, Borger DR, Kim Y, Cosgrove D, Ejaz A, Alexandrescu S, Groeschl RT, Deshpande V, Lindberg JM, Ferrone C, Sempoux C, Yau T, Poon R, Popescu I, Bauer TW, Gamblin TC, Gigot JF, Anders RA, Pawlik TM.
    Ann Surg Oncol; 2014 Nov; 21(12):3827-34. PubMed ID: 24889489
    [Abstract] [Full Text] [Related]

  • 25. Staging, prognostic factors and adjuvant therapy of intrahepatic cholangiocarcinoma after curative resection.
    Li T, Qin LX, Zhou J, Sun HC, Qiu SJ, Ye QH, Wang L, Tang ZY, Fan J.
    Liver Int; 2014 Jul; 34(6):953-60. PubMed ID: 24134199
    [Abstract] [Full Text] [Related]

  • 26. Association of Lymph Node Status With Survival in Patients After Liver Resection for Hilar Cholangiocarcinoma in an Italian Multicenter Analysis.
    Giuliante F, Ardito F, Guglielmi A, Aldrighetti L, Ferrero A, Calise F, Giulini SM, Jovine E, Breccia C, De Rose AM, Pinna AD, Nuzzo G.
    JAMA Surg; 2016 Oct 01; 151(10):916-922. PubMed ID: 27556741
    [Abstract] [Full Text] [Related]

  • 27. Does the extent of lymphadenectomy, number of lymph nodes, positive lymph node ratio and neutrophil-lymphocyte ratio impact surgical outcome of perihilar cholangiocarcinoma?
    Hakeem AR, Marangoni G, Chapman SJ, Young RS, Nair A, Hidalgo EL, Toogood GJ, Wyatt JI, Lodge PA, Prasad KR.
    Eur J Gastroenterol Hepatol; 2014 Sep 01; 26(9):1047-54. PubMed ID: 25051217
    [Abstract] [Full Text] [Related]

  • 28. ESMO Scale for Clinical Actionability of Molecular Targets Driving Targeted Treatment in Patients with Cholangiocarcinoma.
    Verdaguer H, Saurí T, Acosta DA, Guardiola M, Sierra A, Hernando J, Nuciforo P, Miquel JM, Molero C, Peiró S, Serra-Camprubí Q, Villacampa G, Aguilar S, Vivancos A, Tabernero J, Dienstmann R, Macarulla T.
    Clin Cancer Res; 2022 Apr 14; 28(8):1662-1671. PubMed ID: 35042699
    [Abstract] [Full Text] [Related]

  • 29. Clinicopathological prognostic factors after hepatectomy for patients with mass-forming type intrahepatic cholangiocarcinoma: relevance of the lymphatic invasion index.
    Shirabe K, Mano Y, Taketomi A, Soejima Y, Uchiyama H, Aishima S, Kayashima H, Ninomiya M, Maehara Y.
    Ann Surg Oncol; 2010 Jul 14; 17(7):1816-22. PubMed ID: 20135355
    [Abstract] [Full Text] [Related]

  • 30. Impact of IDH1 mutation on clinical course of patients with intrahepatic cholangiocarcinoma: a retrospective analysis from a German tertiary center.
    Kinzler MN, Jeroch J, Klasen C, Himmelsbach V, Koch C, Finkelmeier F, Trojan J, Zeuzem S, Pession U, Reis H, Demes MC, Wild PJ, Walter D.
    J Cancer Res Clin Oncol; 2023 Aug 14; 149(9):6391-6398. PubMed ID: 36757619
    [Abstract] [Full Text] [Related]

  • 31. The prognosis and survival outcome of intrahepatic cholangiocarcinoma following surgical resection: association of lymph node metastasis and lymph node dissection with survival.
    Choi SB, Kim KS, Choi JY, Park SW, Choi JS, Lee WJ, Chung JB.
    Ann Surg Oncol; 2009 Nov 14; 16(11):3048-56. PubMed ID: 19626372
    [Abstract] [Full Text] [Related]

  • 32. Impact of tumor localization on the outcomes of surgery for an intrahepatic cholangiocarcinoma.
    Orimo T, Kamiyama T, Mitsuhashi T, Kamachi H, Yokoo H, Wakayama K, Shimada S, Nagatsu A, Taketomi A.
    J Gastroenterol; 2018 Nov 14; 53(11):1206-1215. PubMed ID: 29721628
    [Abstract] [Full Text] [Related]

  • 33. Prognostic value of lymphadenectomy for long-term outcomes in node-negative intrahepatic cholangiocarcinoma: A multicenter study.
    Yoh T, Cauchy F, Le Roy B, Seo S, Taura K, Hobeika C, Dokmak S, Farges O, Gelli M, Sa Cunha A, Adam R, Uemoto S, Soubrane O.
    Surgery; 2019 Dec 14; 166(6):975-982. PubMed ID: 31421869
    [Abstract] [Full Text] [Related]

  • 34. Routine lymph node dissection may be not suitable for all intrahepatic cholangiocarcinoma patients: results of a monocentric series.
    Li DY, Zhang HB, Yang N, Quan Y, Yang GS.
    World J Gastroenterol; 2013 Dec 21; 19(47):9084-91. PubMed ID: 24379635
    [Abstract] [Full Text] [Related]

  • 35. Clinical implication of tumor site in terms of node metastasis for intrahepatic cholangiocarcinoma.
    Lee W, Jeong CY, Jang JY, Roh YH, Kim KW, Kang SH, Yoon MH, Seo HI, Park JI, Jung BH, Shin DH, Choi YI, Moon HH, Ryu JH, Yang K, Choi CS, Park YH, Nah YW, Kim R, Navarro J, Han DH, Choi GH, Kang CM, Kim KS, Hong SC.
    Eur J Surg Oncol; 2020 May 21; 46(5):832-838. PubMed ID: 31806519
    [Abstract] [Full Text] [Related]

  • 36. Surgical Resection Does Not Improve Survival in Multifocal Intrahepatic Cholangiocarcinoma: A Comparison of Surgical Resection with Intra-Arterial Therapies.
    Wright GP, Perkins S, Jones H, Zureikat AH, Marsh JW, Holtzman MP, Zeh HJ, Bartlett DL, Pingpank JF.
    Ann Surg Oncol; 2018 Jan 21; 25(1):83-90. PubMed ID: 29063296
    [Abstract] [Full Text] [Related]

  • 37. Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection.
    Guglielmi A, Ruzzenente A, Campagnaro T, Pachera S, Valdegamberi A, Nicoli P, Cappellani A, Malfermoni G, Iacono C.
    World J Surg; 2009 Jun 21; 33(6):1247-54. PubMed ID: 19294467
    [Abstract] [Full Text] [Related]

  • 38. Clinical impact of lymph node dissection in surgery for peripheral-type intrahepatic cholangiocarcinoma.
    Morine Y, Shimada M, Utsunomiya T, Imura S, Ikemoto T, Mori H, Hanaoka J, Kanamoto M, Miyake H.
    Surg Today; 2012 Jan 21; 42(2):147-51. PubMed ID: 22124809
    [Abstract] [Full Text] [Related]

  • 39. Association of Liver-Directed Local Therapy With Overall Survival in Adults With Metastatic Intrahepatic Cholangiocarcinoma.
    Sebastian NT, Tan Y, Miller ED, Williams TM, Noonan AM, Hays JL, Abdel-Misih S, Diaz DA.
    JAMA Netw Open; 2019 Sep 04; 2(9):e1911154. PubMed ID: 31517963
    [Abstract] [Full Text] [Related]

  • 40. The prognostic role of lymphovascular invasion and lymph node metastasis in perihilar and intrahepatic cholangiocarcinoma.
    Lurje G, Bednarsch J, Czigany Z, Lurje I, Schlebusch IK, Boecker J, Meister FA, Tacke F, Roderburg C, Den Dulk M, Gaisa NT, Bruners P, Neumann UP.
    Eur J Surg Oncol; 2019 Aug 04; 45(8):1468-1478. PubMed ID: 31053477
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.